315 related articles for article (PubMed ID: 23307209)
1. Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma.
Wen JC; Sai V; Straatsma BR; McCannel TA
JAMA Ophthalmol; 2013 Jan; 131(1):56-61. PubMed ID: 23307209
[TBL] [Abstract][Full Text] [Related]
2. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk.
Huang B; Law MW; Khong PL
Radiology; 2009 Apr; 251(1):166-74. PubMed ID: 19251940
[TBL] [Abstract][Full Text] [Related]
3. Whole body PET/CT for initial staging of choroidal melanoma.
Finger PT; Kurli M; Reddy S; Tena LB; Pavlick AC
Br J Ophthalmol; 2005 Oct; 89(10):1270-4. PubMed ID: 16170114
[TBL] [Abstract][Full Text] [Related]
4. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
[TBL] [Abstract][Full Text] [Related]
5. Utility of the PET-CT scan with (18)F-FDG in a case of choroid melanoma recurrence.
Sabate M; García JR; Valls E; Moragas M; Soler M; Riera E; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):167-8. PubMed ID: 22177294
[No Abstract] [Full Text] [Related]
6. Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients.
Freton A; Chin KJ; Raut R; Tena LB; Kivelä T; Finger PT
Eur J Ophthalmol; 2012; 22(2):236-43. PubMed ID: 21959680
[TBL] [Abstract][Full Text] [Related]
7. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
[TBL] [Abstract][Full Text] [Related]
8. Major trauma & cervical clearance radiation doses & cancer induction.
Richards PJ; Summerfield R; George J; Hamid A; Oakley P
Injury; 2008 Mar; 39(3):347-56. PubMed ID: 17919637
[TBL] [Abstract][Full Text] [Related]
9. Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography.
Tarin TV; Sonn G; Shinghal R
J Urol; 2009 Feb; 181(2):627-32; discussion 632-3. PubMed ID: 19091344
[TBL] [Abstract][Full Text] [Related]
10. Choroidal melanoma with hematogenous spread to the liver: F-18 FDG PET/CT findings.
Bawa M; Sidhu G; Galt JR; Schuster DM; Halkar RK
Clin Nucl Med; 2006 Jun; 31(6):347-8. PubMed ID: 16714898
[No Abstract] [Full Text] [Related]
11. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
Finger PT; Chin KJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070
[TBL] [Abstract][Full Text] [Related]
12. Estimated radiation exposure and cancer risk from CT and PET/CT scans in patients with lymphoma.
Guttikonda R; Herts BR; Dong F; Baker ME; Fenner KB; Pohlman B
Eur J Radiol; 2014 Jun; 83(6):1011-1015. PubMed ID: 24656401
[TBL] [Abstract][Full Text] [Related]
13. 18FDG-PET/CT assessing the absence of cell viability and excluding metastatic disease in a case of necrotic choroidal melanoma.
Romero-Aroca P; Montero-Jaime M; Intriago B; Riu F; Peña-Gonzalez KB; Almena-Garcia M
Eur J Ophthalmol; 2012; 22(2):288-92. PubMed ID: 21725939
[TBL] [Abstract][Full Text] [Related]
14. Computed Tomography Scans in Patients With Young Adult Hip Pain Carry a Lifetime Risk of Malignancy.
Wylie JD; Jenkins PA; Beckmann JT; Peters CL; Aoki SK; Maak TG
Arthroscopy; 2018 Jan; 34(1):155-163.e3. PubMed ID: 29100768
[TBL] [Abstract][Full Text] [Related]
15. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
Rampinelli C; De Marco P; Origgi D; Maisonneuve P; Casiraghi M; Veronesi G; Spaggiari L; Bellomi M
BMJ; 2017 Feb; 356():j347. PubMed ID: 28179230
[No Abstract] [Full Text] [Related]
16. Radiation-related cancer risk associated with radiographic imaging.
Finger PT; Freton A; Pavlick A
JAMA Ophthalmol; 2013 Sep; 131(9):1248-9. PubMed ID: 24030341
[No Abstract] [Full Text] [Related]
17. Radiation-related cancer risk associated with radiographic imaging--reply.
Wen JC; Sai V; Straatsma BR; McCannel TA
JAMA Ophthalmol; 2013 Sep; 131(9):1249. PubMed ID: 24030343
[No Abstract] [Full Text] [Related]
18. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
[TBL] [Abstract][Full Text] [Related]
19. Patient doses from PET-CT procedures.
Avramova-Cholakova S; Ivanova S; Petrova E; Garcheva M; Vassileva J
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):430-3. PubMed ID: 25848105
[TBL] [Abstract][Full Text] [Related]
20. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
